Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Total Market vs Total World funds offer different diversification and regional exposure. This primer outlines how each fits retirement goals.
28,570 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
XRP's price fell in the first quarter, but XRP Ledger usage climbed sharply as stablecoins and tokenized assets expan...
e.l.f. beauty shares down have caught the attention of investors as momentum slows and margins feel pressure. This ar...
Is Pfizer stock undervalued in the crowded healthcare space? This deep dive weighs cash flow, dividends, pipeline pot...
SpaceX is taking on massive debt to accelerate its AI ambitions. This in-depth analysis explains the financing move, ...
When big builders cut prices to move inventory, investors win—if they know how to structure deals. This guide breaks ...
A Friday deadline intensifies a clash between Anthropic and the Pentagon over how its Claude AI models may be used by...
President Trump dropped a surprise line about Cuba, saying Havana has no money and floated a possible friendly takeov...
A new nationwide survey finds some households earning more than $300,000 a year report paycheck-to-paycheck constrain...
In 2026, three popular tech ETFs tell three different stories about how to own technology: FTEC offers broad exposure...
The latest data show the U.S. public debt now tops the nation's GDP, a milestone with potential implications for rate...
A high-profile clash between the Pentagon and a leading AI firm hits markets and wallets. Regulators, investors, and ...